NASDAQ:AAPG

Ascentage Pharma Group Internat Stock Insider Trading

*Your capital is at risk

$16.77

-0.280 (-1.64%)

At Close: Jun 26, 2026

Ascentage Pharma Group Internat Stock Insider Power

Based on the 71 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 4.91M and sold 0 AAPG shares in the last 71 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 71 transactions)	100.00
● Buy	4.91M shares
● Sell	0 shares
100% Buy Activity Weak Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 18, 2026 Buy	Restricted stock units	Cao Jin Chief Accounting Officer	Officer	12 883 Value: $309.8K
Mar 18, 2026 Buy	Restricted share units	Wei Ren Director	Director	28 850 Value: $693.8K
Mar 18, 2026 Buy	Options	Wei Ren Director	Director	18 850 Value: $153.4K
Mar 18, 2026 Buy	Ordinary Shares	Ye Changqing Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted share units	Ye Changqing Director	Director	28 850 Value: $693.8K
Mar 18, 2026 Buy	Restricted share units	Yu Debra Director	Director	27 965 Value: $672.6K
Mar 18, 2026 Buy	Ordinary Shares	Lu Simon Dazhong Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted share units	Lu Simon Dazhong Director	Director	27 965 Value: $672.6K
Mar 18, 2026 Buy	Ordinary Shares	Sidransky David Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted share units	Sidransky David Director	Director	28 850 Value: $693.8K
Mar 18, 2026 Buy	Ordinary Shares	Wang Shaomeng Director	Director	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Wang Shaomeng Director	Director	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Wang Shaomeng Director	Director	0 Value: $0
Mar 18, 2026 Buy	Options	Wang Shaomeng Director	Director	17 965 Value: $146.2K
Mar 18, 2026 Buy	Restricted share units	Wang Shaomeng Director	Director	27 965 Value: $672.6K
Mar 18, 2026 Buy	Restricted share units	Lippman Marc E Director	Director	27 965 Value: $672.6K
Mar 18, 2026 Buy	Ordinary Shares	Knapp Thomas J SVP/general Counsel	Officer	0 Value: $0
Mar 18, 2026 Buy	Options	Knapp Thomas J SVP/general Counsel	Officer	38 938 Value: $317.0K
Mar 18, 2026 Buy	Restricted stock units	Knapp Thomas J SVP/general Counsel	Officer	38 938 Value: $936.5K
Mar 18, 2026 Buy	Restricted share units	Bozilenko Marina Director	Director	27 965 Value: $672.6K
Mar 18, 2026 Buy	Ordinary Shares	Wei Ren Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted share units	Zhai Yifan Chief Medical Officer	Officer	103 364 Value: $2.49M
Mar 18, 2026 Buy	Options	Zhai Yifan Chief Medical Officer	Officer	103 364 Value: $841.4K
Mar 18, 2026 Buy	Ordinary Shares	Zhai Yifan Chief Medical Officer	Officer	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Zhai Yifan Chief Medical Officer	Officer	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks